
Chevron (CVX) is currently assessed as undervalued, trading at $136.54, with analysts projecting EPS of $6.91 for the current fiscal year and $8.66 for the next, despite a recent reduction in its share buyback program viewed as a strategic move to manage leverage. The company is focusing on free cash flow (FCF) generation, with levered FCF reaching $13.6 billion and a 6% free cash flow yield, while reducing capital expenditure to $15 billion for 2025, signaling a commitment to efficient capital allocation and shareholder returns, though some analysts caution about the long-term impact of reduced capex on growth.
Chevron Corporation (CVX), trading at $136.54 and assessed by InvestingPro as undervalued, demonstrates a resilient financial strategy amidst a dynamic global energy market. The company's conservative approach is highlighted by a moderate debt-to-equity ratio of 0.2, a 55-year history of dividend payments (currently yielding 5.01% with 37 consecutive years of increases), and an aggressive share buyback program, which was recently moderated in early May 2025 as a strategic move to manage leverage rather than an indicator of financial distress. Analysts project earnings per share (EPS) to grow from $6.91 in the current fiscal year to $8.66 in the following year. Chevron is intensifying its focus on operational efficiency and cost management, aiming for a significant free cash flow (FCF) inflection point in 2025, with current levered FCF standing at $13.6 billion and an FCF yield of 6%. This is supported by a reduced capital expenditure (capex) budget of $15 billion for 2025, below prior estimates, and projected to decline further, signaling a prioritisation of FCF generation. While the pending Hess Corporation acquisition is expected to enhance its competitive stance and analysts like RBC Capital Markets maintain an Outperform rating with a $175 price target, potential headwinds include the long-term growth implications of reduced capex and inherent oil price volatility. InvestingPro rates Chevron's financial health as "FAIR" (2.44/5), with notable strength in profitability (3.04/5) and cash flow (2.94/5).
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately positive
Sentiment Score
0.65
Ticker Sentiment